Sildenafil is already approved by the FDA to treat erectile dysfunction and pulmonary hypertension. According to a recent MedicalXpress article, the drug is now a candidate to treat and prevent Alzheimer’s disease as well. A new study, published in Nature Aging, used an algorithm to determine if any FDA-approved drugs could be potential therapies for Alzheimer’s disease. After sifting through a database of over 7 million patients, the team found that sildenafil was associated with 69% fewer incidences of the neurodegenerative disease.
ED Drug Could Have Alzheimer’s Application
The FDA-approved therapy is associated with a 69% reduction in Alzheimer’s disease incidence.
Dec 10, 2021
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
